selected publications
- Sexual dimorphism shapes renal metabolic adaptation to a ketogenic diet. Cell reports. 2026 Academic Article GET IT
- Preclinical Pharmacokinetics of DM5167, a Novel Selective PARP1 Inhibitor. Pharmaceutical research. 2025 Academic Article GET IT
-
Dietary fibre-adapted gut microbiome clears dietary fructose and reverses hepatic steatosis.
Nature metabolism.
2025
Academic Article
GET IT
Times cited: 9 - Intestinal catabolism of dietary fructose promotes obesity and insulin resistance via ileal lacteal remodeling. bioRxiv : the preprint server for biology. 2025 Article GET IT
-
Cross-organ metabolite production and consumption in healthy and atherogenic conditions.
Cell.
2025
Academic Article
GET IT
Times cited: 5 -
Aberrant splicing in Huntington's disease accompanies disrupted TDP-43 activity and altered m6A RNA modification.
Nature neuroscience.
2025
Academic Article
GET IT
Times cited: 27 - Sex-dependent metabolic remodeling of kidneys revealed by arteriovenous metabolomics. bioRxiv : the preprint server for biology. 2024 Article GET IT
- Aberrant splicing in Huntington's disease via disrupted TDP-43 activity accompanied by altered m6A RNA modification. bioRxiv : the preprint server for biology. 2023 Article GET IT
-
MAPK13 stabilization via m6A mRNA modification limits anticancer efficacy of rapamycin.
The Journal of biological chemistry.
2023
Academic Article
GET IT
Times cited: 3 -
m6A in the Signal Transduction Network.
Molecules and cells.
2022
Information Resource
GET IT
Times cited: 28 -
Pharmacological Intervention Targeting FAF1 Restores Autophagic Flux for α-Synuclein Degradation in the Brain of a Parkinson's Disease Mouse Model.
ACS chemical neuroscience.
2022
Academic Article
GET IT
Times cited: 5 -
Protective effects of PARP1-inhibitory compound in dry age-related macular degeneration.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
2020
Academic Article
GET IT
Times cited: 11 -
PARP1 Impedes SIRT1-Mediated Autophagy during Degeneration of the Retinal Pigment Epithelium under Oxidative Stress.
Molecules and cells.
2020
Academic Article
GET IT
Times cited: 30 -
Protective effect of RIPK1-inhibitory compound in in vivo models for retinal degenerative disease.
Experimental eye research.
2018
Academic Article
GET IT
Times cited: 33 -
Kinase-independent role of nuclear RIPK1 in regulating parthanatos through physical interaction with PARP1 upon oxidative stress.
Biochimica et biophysica acta. Molecular cell research.
2017
Academic Article
GET IT
Times cited: 20 -
A novel RIPK1 inhibitor that prevents retinal degeneration in a rat glaucoma model.
Experimental cell research.
2017
Academic Article
GET IT
Times cited: 42 -
AIF-independent parthanatos in the pathogenesis of dry age-related macular degeneration.
Cell death & disease.
2017
Academic Article
GET IT
Times cited: 69